User:mariahffji905328

Gemtuzumab Ozogamicin treatment represents a significant advance in the therapy of relapsed leukemic leukemia, especially severe leukemic cancer (AML). The agent pairs a humanized protein

https://www.targetmol.com/compound/gemtuzumab